In the study of a mucosal vaccine for influenza, we need to evaluate the immune responses against vaccine in the serum and nasal washes. Serum IgG antibodies and mucosal secretory IgA antibodies are needed to evaluate. We use the mammalian protein expression system to produce the strain-specific influenza virus HA proteins to check the antibody titers. Moreover, we take the advantage of the expression system to produce the antibodies itself which were induced by the mucosal vaccine to characterize the effectiveness of the vaccine.
Microbiology
Biotechnology
Cancer Research
Infectious Disease
Immunology
Molecular Biology
Cell Culture
Genetics
Cell Biology
Molecular Diagnostics
Clinical Research
Drug Discovery
Biomarkers
Genomics
Antibodies
Asia36%
North America35%
Africa9%
Europe8%
South America8%
Oceania2%
Website Visitors100%
Student31%
Research Scientist18%
Facility/Department Manager7%
Executive5%
Scientist5%
Medical Laboratory Technician5%
Educator/Faculty5%
Medical Doctor/Specialist5%
Post Doc4%
Marketing/Sales2%
Biologist2%
Clinical Laboratory Scientist2%
Pharmacist2%
Lab Management1%
Veterinarian1%
Chemist1%
Consultant1%
Academic Institution13%
Biotech Company6%
Life Science Company5%
Research Institute3%
Clinical Laboratory3%
Government3%
Ambulatory Care2%
Medical School2%
Media1%
Manufacturer - Other1%
Hospital1%
Veterinary School1%
Private Practice1%
Government/public1%
Other5%